Scientific Literature Search

Open access

Impact of type 2 diabetes mellitus on acute levodopa responsiveness in Parkinson's disease: A Multicenter retrospective study.

Stockmann O, Ye L, Buhmann C, Maass F, van Riesen C, Weinrich C, Wegner F, Höllerhage M, Pötter-Nerger M, Klietz M.

Clin Park Relat Disord · 2026-09-15

DOI: 10.1016/j.prdoa.2026.100502PMID: 42824654

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.

Antonini A, Gross RE, De Leon M, Kwok K, Foltynie T, Höglinger G, Gasser T, Corvol JC, Pedrosa DJ, Volkmann J, Henchcliffe C.

J Parkinsons Dis · 2026-09-15

DOI: 10.1177/1877718x261481704PMID: 42742463

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Depression in Parkinson's Disease: Real-World Prescribing Patterns and Treatment Dynamics from a Nationwide Greek Cohort.

Karageorgiou V, Skapinakis P, Michopoulos I, Mitrou P, Thireos E, Gournellis R.

Mov Disord Clin Pract · 2026-09-15

DOI: 10.1002/mdc3.70809PMID: 42742618

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Maintenance Electroconvulsive Therapy Emphasizing Relapse Prevention in Parkinsonian Syndromes With Psychiatric Comorbidities.

Sherpa TD, Biswas T, Thakkar V, Mishra A, Mishra BR.

J ECT · 2026-09-15

DOI: 10.1097/yct.0000000000001318PMID: 42743949

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

The mechanism of cerebellar involvement in cognitive disorders and therapeutic prospects.

Chen X, Fu P, Kang C, Wu Y, Wu Y, Luo X, Chen L, Liu H, Ouyang J, Zhang M, Yin X, Chen Z.

Exp Gerontol · 2026-09-15

DOI: 10.1016/j.exger.2026.113324PMID: 42744009

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?

Buck SA, Madhavan SS, Sanders LH.

Mol Neurodegener Adv · 2026-09-14

DOI: 10.1186/s44477-026-00047-8PMID: 42745993

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Cu/Cu<sub>2</sub>O-embedded carbon from Cu-MOF integrated with MWCNTs-COOH for sensitive levodopa detection in biological samples.

Ma N, Wei A, Peng H, Xie L, Jin Y, Li G.

Colloids Surf B Biointerfaces · 2026-09-12

DOI: 10.1016/j.colsurfb.2026.116177PMID: 42743869

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.

Langeskov-Christensen M, Borghammer P, Østergaard SD, Rohde C.

Parkinsonism Relat Disord · 2026-09-12

DOI: 10.1016/j.parkreldis.2026.108984PMID: 42766893

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Isolated auditory hallucinations as the initial neuropsychiatric manifestation of dementia with Lewy bodies: diagnostic pathway and individualized therapy (a case report).

Hou L, Ma X, Wang C, Ji L, Peng P.

Front Psychiatry · 2026-09-11

DOI: 10.3389/fpsyt.2026.1935514PMID: 42798501

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Reversible exacerbation of parkinsonism during epirubicin-cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson's disease.

Wakamatsu N, Norimura S, Nakagawa M, Hirao A, Mukai M, Urai Y, Toda T, Tsuji S, Mitsui J.

Neurol Sci · 2026-09-11

DOI: 10.1007/s10072-026-09361-1PMID: 42726292

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

Vogt HK, Pojani C, Devonport J, McGown A, Firth G, Doykov I, Nikolaenko V, Anagianni S, Valdivia LE, Khalil Y, Bodnár N, Kállay C, Dadswell C, Gonzalez-Mendez R, Purchase R, Platt FM, Zacconi FCM, Geard AF, Heywood WE, Mills K, Mills PB, Rahim AA, Rihel J, Wilson SW, Kostakis GE, Spencer J, Tuschl K.

Biochem Pharmacol · 2026-09-11

DOI: 10.1016/j.bcp.2026.118465PMID: 42727654

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Advances in Novel Drug Delivery Systems for Targeting the Brain: Overcoming Barriers and Enhancing Therapeutic Efficacy.

Bhise MR, Thejomoorthy K, Kumar M, Patel PKN, Mahajan V, Naquvi KJ, Ansari I, Kumar A.

Curr Drug Deliv · 2026-09-11

DOI: 10.2174/0115672018474663260907142216PMID: 42764574

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

20.463 articles found

Impact of type 2 diabetes mellitus on acute levodopa responsiveness in Parkinson's disease: A Multicenter retrospective study.

Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.

Depression in Parkinson's Disease: Real-World Prescribing Patterns and Treatment Dynamics from a Nationwide Greek Cohort.

Maintenance Electroconvulsive Therapy Emphasizing Relapse Prevention in Parkinsonian Syndromes With Psychiatric Comorbidities.

The mechanism of cerebellar involvement in cognitive disorders and therapeutic prospects.

Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?

Cu/Cu<sub>2</sub>O-embedded carbon from Cu-MOF integrated with MWCNTs-COOH for sensitive levodopa detection in biological samples.

Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.

Isolated auditory hallucinations as the initial neuropsychiatric manifestation of dementia with Lewy bodies: diagnostic pathway and individualized therapy (a case report).

Reversible exacerbation of parkinsonism during epirubicin-cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson's disease.

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

Advances in Novel Drug Delivery Systems for Targeting the Brain: Overcoming Barriers and Enhancing Therapeutic Efficacy.

Filters